# Aflibercept for Retinopathy in the Real World

> **NCT02812030** · — · WITHDRAWN · sponsor: **Timothy Jones**

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **OTHER:** National Eye Institute Visual Functioning Questionnaire

## Key facts

- **NCT ID:** NCT02812030
- **Lead sponsor:** Timothy Jones
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Superceded by a larger trial by the pharmaceutical company
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02812030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02812030, "Aflibercept for Retinopathy in the Real World". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02812030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*